Sugi Predict

Sugi Predict / Compounds / Ether

Ether

Ether

SCHEMBL7982613

CCOCC.CN1CCC2(C)c3cc(O)ccc3N(C)C12

nearest known ligand 0.83

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 7/20 0.83
▸ CYP2D6 P10635 3/20 0.83
▸ MEN1 O00255 3/20 0.83
▸ KMT2A Q03164 3/20 0.83
▸ TP53 P04637 2/20 0.83
▸ ALOX15 P16050 2/20 0.83
▸ MAPT P10636 2/20 0.83
▸ CYP1A2 P05177 2/20 0.83
▸ HIF1A Q16665 2/20 0.83
▸ MTOR P42345 1/20 0.83
▸ CYP3A4 P08684 1/20 0.83
▸ CYP2C9 P11712 1/20 0.83
▸ CYP2C19 P33261 1/20 0.83
▸ THPO P40225 1/20 0.83
▸ HSD17B10 Q99714 1/20 0.83
▸ FTO Q9C0B1 1/20 0.83
▸ BLM P54132 3/20 0.69
▸ ALDH1A1 P00352 2/20 0.69
▸ LMNA P02545 2/20 0.69
▸ SMN1; SMN2 Q16637 2/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22215232 0.91 KDM4E (1.00) KDM4ECYP2D6MEN1KMT2ATP53
SCHEMBL12849250 0.91 KDM4E (1.00) KDM4ECYP2D6MEN1KMT2ATP53
SCHEMBL12083012 0.91 KDM4E (1.00) KDM4ECYP2D6MEN1KMT2ATP53
SCHEMBL30142606 0.91 KDM4E (1.00) KDM4ECYP2D6MEN1KMT2ATP53
SCHEMBL2453645 0.91 KDM4E (1.00) KDM4ECYP2D6MEN1KMT2ATP53
SCHEMBL150460 0.91 KDM4E (1.00) KDM4ECYP2D6MEN1KMT2ATP53
SCHEMBL150459 0.91 KDM4E (1.00) KDM4ECYP2D6MEN1KMT2ATP53
Carbamic Acid SCHEMBL2453716 0.84 KDM4E (0.85) KDM4ECYP2D6MEN1KMT2ATP53
SCHEMBL31663895 0.84 KDM4E (0.85) KDM4ECYP2D6MEN1KMT2ATP53
SCHEMBL4104614 0.82 KDM4E (0.81) KDM4ECYP2D6MEN1KMT2ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6297237-B1 Process for the preparation of aminocarbonyl derivatives of geneseroline having selective brain anticholinesterase activity CHIESI FARMACEUTICI S.P.A. (IT) 2001-10-02 — — US disclosed
CN-1278264-A Process for preparing aminocarbonyl derivatives of chrysogenin having selective cerebral anticholinesterase activity CHIESI FARMACEUTIICI S P A (IT) 2000-12-27 — — CN disclosed
EP-1023297-A1 A PROCESS FOR THE PREPARATION OF AMINOCARBONYL DERIVATIVES OF GENESEROLINE HAVING SELECTIVE BRAIN ANTICHOLINESTERASE ACTIVITY CHIESI FARMACEUTICI S.p.A. (IT) 2000-08-02 — — EP disclosed
EP-0946560-A1 METHOD OF PREPARATION OF PHYSOSTIGMINE CARBAMATE DERIVATIVES FROM ESEROLINE ETHERS HOECHST MARION ROUSSEL, INC. (US) 1999-10-06 — — EP disclosed
EP-0946560-A1 METHOD OF PREPARATION OF PHYSOSTIGMINE CARBAMATE DERIVATIVES FROM ESEROLINE ETHERS HOECHST MARION ROUSSEL, INC. (US) 1999-10-06 — — EP disclosed
WO-1999019329-A1 A PROCESS FOR THE PREPARATION OF AMINOCARBONYL DERIVATIVES OF GENESEROLINE HAVING SELECTIVE BRAIN ANTICHOLINESTERASE ACTIVITY CHIESI FARMACEUTICI S.P.A. (IT) 1999-04-22 — — WO disclosed
WO-1998027096-A1 METHOD OF PREPARATION OF PHYSOSTIGMINE CARBAMATE DERIVATIVES FROM ESEROLINE ETHERS HOECHST MARION ROUSSEL, INC. (US) 1998-06-25 — — WO disclosed
WO-1998027096-A1 METHOD OF PREPARATION OF PHYSOSTIGMINE CARBAMATE DERIVATIVES FROM ESEROLINE ETHERS HOECHST MARION ROUSSEL, INC. (US) 1998-06-25 — — WO disclosed
US-5677457-A REACTING ESERETHOLE WITH LITHIUM BROMIDE AND HYDROBROMIC ACID TO FORM ESEROLINE COMPOUND, TREATING WITH ISOCYANATE OR CARBONYLDIIMIDAZOLE HOECHST MARION ROUSSEL, INC. (US) 1997-10-14 — — US disclosed
US-5677457-A REACTING ESERETHOLE WITH LITHIUM BROMIDE AND HYDROBROMIC ACID TO FORM ESEROLINE COMPOUND, TREATING WITH ISOCYANATE OR CARBONYLDIIMIDAZOLE HOECHST MARION ROUSSEL, INC. (US) 1997-10-14 — — US disclosed